Publication
M. Fluorescence hysteroscopy using 5-aminolevulinic: A descriptive study
Journal Paper/Review - Aug 25, 2003
Hornung René, Wyss Pius, Degen Andrea, Caduff Rosmarie, Haller Urs, Fehr Mathias K.
Units
Doi
Link
Contact
Citation
Type
Journal
Publication Date
Pages
Brief description/objective
Background and Objectives
To assess the feasibility of fluorescence hysteroscopy following topical ALA application and to descript the optical appearance of normal and neoplastic endometrium.
Study Design/Materials and Methods
Fifty-four patients scheduled for routine hysteroscopy and D&C were assigned to the study group using topically applied ALA. Two milliliters of a 2% 5-ALA-solution at pH = 4.0 (ASAT AG/Zug, Switzerland) was administrated into the uterine cavity 4 hours before fluorescence hysteroscopy, using a STORZ-D-Light (Tuttlingen, Germany) system. Hysteroscopic findings were compared to the histological diagnosis of hematoxylin & eosin (H&E) stained sections. In the study group, 60 histological specimens were taken (47 materials of curettage and 13 targeted biopsies). The percentage of fluorescence positive patients was calculated.
Results
The rate of fluorescent endometrial samples was low in atrophic endometrium 1/16 (6.2%). Endometrial carcinoma were diagnosed in two patients. Both cases exhibited selective and intense PpIX-mediated red fluorescence. Fluorescence hysteroscopy could not differentiate between hyperplastic areas with or without atypia. Minimal uterine cramps or discomfort following ALA instillation were complained by 30 (56%) patients, no pain was indicated by 24 patients (44%).
Conclusions
Fluorescence hysteroscopy following intrauterine application of ALA is feasible. Cancerous, hyperplastic, and secretory endometrial tissue showed high red fluorescence.